HBSP (USA)
-
Fresh Connections (Spanish Version)
West, Jonathan; Harmeling, Susan S.; Kasper, Christian G.Case HBS-607S02Service and Operations ManagementMary Alice McKenzie se enfrenta a numerosos problemas en el crecimiento de su negocio de alimentos frescos preparados a base de Vermont. Ella tiene que hacer frente a problemas operacionales inmediatas - como los cuellos de botella y las decisiones de equipo de capital -, así como decidir sobre una posición estratégica a largo plazo. Este caso se investiga cómo se puede estructurar sus operaciones de hoy en día para aprovechar el crecimiento cont...Starting at €8.20
-
Capturing Confectionery (D) (Spanish version)
Collis, David J.; Stuart, Toby; Smith, TroyCase HBS-708S48StrategyIn late 2002, global confectionery and beverage maker Cadbury Schweppes needed to decide whether or not to make an acquisition bid for Adams, an underperforming gum company which had been put up for sale by pharmaceutical giant Pfizer. Examining the decision from a strategic perspective, the (A) case provides brief histories of the two companies; traces the global confectionery industry, focusing especially on chocolate and gum; and details the a...Starting at €5.74
-
Signode Industries, Inc. (A) (Spanish Version)
Moriarty, Rowland T., Jr.; May, David; Swartz, GordonCase HBS-502S10Marketingdivisión de envasado Signode Industries fabrica flejes de acero y plástico. En 1981, la compañía experimentó la mayor compra apalancada en la historia corporativa EE.UU.. El caso se centra en la necesidad de la división de envasado para mantener una alta rentabilidad en un mercado a la baja de flejes de acero. Desde 1974, ha ido perdiendo Signode 1% por año del mercado de flejes de acero. Desde entonces, ha habido también una erosión significativ...Starting at €8.20
-
The MonoSpace Launch in Germany (Spanish version)
Narayandas, Das; Swartz, GordonCase HBS-503S07MarketingFocuses on the launch of a new elevator product in Germany. In 1996, global construction slumps and low differentiation among competitive offerings has led to significant price competition and margin erosion in the elevator industry. In these circumstances, KONE, one of the global players in this industry, has developed the Monospace elevator product that uses revolutionary technologies. This new product is expected to have a significant impact o...Starting at €8.20
-
Fortis Industries, Inc. (B) (Spanish Version)
Moriarty, Rowland T., Jr.; Swartz, GordonCase HBS-514S01MarketingDescribe si la empresa adopta la política de precios-flex discutido en el caso (A). aumento de precios en los flejes de metal materias primas se rescinde por la industria del acero.Starting at €5.74
-
Cooper Industries' Corporate Strategy (A) (Spanish version)
Collis, David J.; Stuart, TobyCase HBS-306S08StrategyDescribes the development of a successful corporate strategy based on the acquisition and subsequent consolidation of low-technology manufacturing companies. Starting with a company history and discussion of current business segments, the case goes on to detail the innovation of corporate headquarters in strategy formulation and operations. Highlights the synergistic possibilities in alike acquisitions and addresses the issue of long-term value c...Starting at €8.20
-
Guerra en el sector de la alimentación de animales domésticos (B)
Collis, David J.; Stuart, TobyCase HBS-312S04StrategyDescribe el concurso para la adquisición de Anderson Clayton como actores de la industria compiten por uno de los siete principales fabricantes de alimentos para perros.Starting at €5.74
-
Guerra en el sector de la alimentación de animales domésticos (C)
Collis, David J.; Stuart, TobyCase HBS-312S05StrategyDescribe acontecimientos importantes en la industria de alimentos para mascotas en 1987 y 1988, centrándose en las interacciones competitivas entre los principales actores de la industria.Starting at €5.74
-
Time Life, Inc. (B) (Spanish version)
Garvin, David A.; West, JonathanCase HBS-314S01StrategyProvides a brief update to the (A) case.Starting at €5.74
-
Bet on One Big Idea--or Diversify? (HBR Case Study and Commentary)
Stuart, TobyArticle HBS-R1311M-EStrategyA unique probiotic formulation, L-39, has great promise as a pharmaceutical treatment for a common illness. When it hits a stumbling block in its latest clinical trial, Hilde Dach, the scientist leading the research at German drug maker Caliska, faces the prospect that the company may want to reimagine her product as a nutraceutical, because the regulatory hurdles would be easier to clear. Is the company merely hedging its bets to avoid big losse...Starting at €8.20